LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 178 filers reported holding LEGEND BIOTECH CORP in Q2 2024. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $334,174 | – | 4,841 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
| JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
| HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
| Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
| Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
| Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
| Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
| INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |